Orient Pharma (Taiwan) Price on August 9, 2023
| 4166 Stock | TWD 36.80 0.15 0.41% |
If you're considering investing in Orient Stock, it is important to understand the factors that can impact its price. As of today, the current price of Orient Pharma stands at 36.80, as last reported on the 27th of December, with the highest price reaching 36.90 and the lowest price hitting 35.90 during the day. Orient Pharma appears to be not too volatile, given 3 months investment horizon. Orient Pharma maintains Sharpe Ratio (i.e., Efficiency) of 0.15, which implies the firm had a 0.15% return per unit of risk over the last 3 months. By analyzing Orient Pharma's technical indicators, you can evaluate if the expected return of 0.69% is justified by implied risk. Please evaluate Orient Pharma's Risk Adjusted Performance of 0.1177, semi deviation of 3.87, and Coefficient Of Variation of 725.84 to confirm if our risk estimates are consistent with your expectations.
Orient Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Orient |
Sharpe Ratio = 0.1466
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 4166 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.71 actual daily | 41 59% of assets are more volatile |
Expected Return
| 0.69 actual daily | 13 87% of assets have higher returns |
Risk-Adjusted Return
| 0.15 actual daily | 11 89% of assets perform better |
Based on monthly moving average Orient Pharma is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Orient Pharma by adding it to a well-diversified portfolio.
Orient Pharma Valuation on August 9, 2023
It is possible to determine the worth of Orient Pharma on a given historical date. On August 9, 2023 Orient was worth 21.7 at the beginning of the trading date compared to the closed value of 22.2. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Orient Pharma stock. Still, in general, we apply an absolute valuation method to find Orient Pharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Orient Pharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Orient Pharma's related companies.
| Open | High | Low | Close | Volume | |
| 22.00 | 22.50 | 21.85 | 21.85 | 19,272 | |
08/09/2023 | 21.70 | 22.30 | 21.50 | 22.20 | 20,369 |
| 21.60 | 22.25 | 18.80 | 21.05 | 265,185 |
| Backtest Orient Pharma | | | Orient Pharma History | | | Orient Pharma Valuation | Previous | Next |
Orient Pharma Trading Date Momentum on August 9, 2023
| On August 10 2023 Orient Pharma Co was traded for 21.05 at the closing time. The highest price during the trading period was 22.25 and the lowest recorded bid was listed for 18.80 . The volume for the day was 265.2 K. This history from August 10, 2023 contributed to the next trading day price decline. The daily price change to the next closing price was 5.18% . The trading delta at closing time to the current price is 10.36% . |
Orient Pharma Fundamentals Correlations and Trends
By evaluating Orient Pharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Orient Pharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Orient financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Orient Pharma Stock history
Orient Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Orient is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Orient Pharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Orient Pharma stock prices may prove useful in developing a viable investing in Orient Pharma
Orient Pharma Co., Ltd. researches, develops, manufactures, and sells drugs in Taiwan and internationally. Orient Pharma Co., Ltd. is a subsidiary of Orient Europharma Co., Ltd. ORIENT PHARMA operates under Drug Manufacturers - Major classification in Taiwan and is traded on Taiwan OTC Exchange.
Orient Pharma Stock Technical Analysis
Orient Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Orient Pharma Period Price Range
Low | December 27, 2024
| High |
0.00 | 0.00 |
Orient Pharma Co cannot be verified against its exchange. Please verify the symbol is currently traded on Taiwan OTC Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Orient Pharma December 27, 2024 Market Strength
Market strength indicators help investors to evaluate how Orient Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Orient Pharma shares will generate the highest return on investment. By undertsting and applying Orient Pharma stock market strength indicators, traders can identify Orient Pharma Co entry and exit signals to maximize returns
Orient Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Orient Pharma's price direction in advance. Along with the technical and fundamental analysis of Orient Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Orient to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1177 | |||
| Jensen Alpha | 0.6066 | |||
| Total Risk Alpha | 0.3738 | |||
| Sortino Ratio | 0.114 | |||
| Treynor Ratio | 1.48 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Orient Stock Analysis
When running Orient Pharma's price analysis, check to measure Orient Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orient Pharma is operating at the current time. Most of Orient Pharma's value examination focuses on studying past and present price action to predict the probability of Orient Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orient Pharma's price. Additionally, you may evaluate how the addition of Orient Pharma to your portfolios can decrease your overall portfolio volatility.